Who we are
AtomVie is a global leader in the radiopharmaceutical industry dedicated to transforming patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases.
What we do
AtomVie offers services for the GMP manufacturing and global distribution of radiopharmaceuticals:
Process & Analytical Method Development & Validation
Who we work with
AtomVie and Isotopia are collaborating to strengthen the global supply of the most commonly used radioisotope for targeted radiotherapy, lutetium-177 (Lu-177).
Since Lu-177 is more commonly used for radiotherapeutics, Isotopia has developed a new production technology for non-carrier added (n.c.a.) Lu-177 to ensure redundancy and shorter delivery times. To meet increasing supply demands in North America, this production technology has been successfully transferred into AtomVie's current GMP facility. AtomVie has already shipped its first doses of commercial non-carrier added (n.c.a.) Lu-177 and achieved a stable and reliable supply.
“When I joined the company as a Senior Process Chemist, I was looking for new development opportunities. What I got was so much ...” Read more
- Svetoslav Bratovanov PhD, Lead Radiopharmaceutical Technology